Latest Regulatory News

CAR Group Limited reported a strong FY25 with revenue up 8% to $1.18 billion and net profit after tax rising 12% to $293 million, while announcing a leadership transition as CEO Cameron McIntyre steps down.

ResMed Inc. reported a robust 10% increase in revenue to $5.15 billion for fiscal 2025, driven by strong demand in sleep and breathing health devices and residential care software. The company also expanded its diagnostic capabilities with the acquisition of VirtuOx, positioning itself for further growth in home-based health solutions.

MAC Copper has secured a crucial regulatory green light from the South African Reserve Bank, advancing Harmony Gold’s proposed acquisition. Shareholders are now gearing up to vote on the deal at meetings scheduled for late August.

Metro Performance Glass is set to strengthen its balance sheet and support its turnaround strategy through a $15 million to $24 million equity raise, with Amari Metals Australia poised to become the majority shareholder. This recapitalisation aims to reduce debt and improve operational focus amid challenging market conditions.

Donaco International Limited’s shares have been suspended from trading on the ASX following court approval of its acquisition by On Nut Road Limited. This marks a significant step in the company’s transition under new ownership.

Platinum Capital Limited has formally cancelled its planned scheme meeting following the withdrawal of a proposed restructure, yet the scheduled general meeting will proceed as planned on 12 August 2025.

Renergen Limited confirms all conditions for its acquisition scheme with ASP Isotopes Inc. have been met or waived, while outlining a contentious cash settlement for Share Appreciation Rights holders.

West Coast Silver Limited has responded to an ASX query about recent share price and volume spikes, confirming no undisclosed material information and providing an update on its ongoing exploration assay program.

American West Metals has launched an offer of over 104 million new options to select investors and advisors, potentially raising $6.28 million upon exercise. The move aims to enhance liquidity and support ongoing exploration projects.

AVITA Medical reported a 21% revenue increase in Q2 2025 driven by expanded sales and new product launches, yet continues to face net losses and liquidity challenges requiring loan covenant waivers.

AVITA Medical has filed its Q2 2025 Form 10-Q, reaffirming its leadership in acute wound care with its FDA-approved RECELL System and expanding international footprint.

Wrkr Limited is raising approximately A$15 million through an institutional placement to accelerate growth amid upcoming Payday Super reforms and market opportunities.